ResearcherGuangzhou Medical UniversityActive in the last 2 years
Jianhong An
Matched on ORCID iD 0000-0001-6004-3713. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 3
- Up-regulated IL-36 expression promotes a pro-tumorigenic phenotype in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gendis.2025.101973↗
- GATA6 in pancreatic cancer initiation and progression. First author DOI 10.1016/j.gendis.2024.101353↗
- Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation of FOXM1 expression. Co-author DOI 10.1016/j.gendis.2023.101203↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keping Xie · 3 shared papers, 2024–2026 · strength 0.87
- Paper GATA6 in pancreatic cancer initiation and progression. DOI 10.1016/j.gendis.2024.101353↗
- Paper Up-regulated IL-36 expression promotes a pro-tumorigenic phenotype in pancreatic ductal adenocarcinoma. DOI 10.1016/j.gendis.2025.101973↗
- Paper Down-regulation of microRNA-23a promotes pancreatic ductal adenocarcinoma initiation and progression by up-regulation o… DOI 10.1016/j.gendis.2023.101203↗
- Muyuan Ma · 1 shared paper, 2025 · strength 0.37
- Lixin Liang · 1 shared paper, 2024 · strength 0.20
- Tingting Jiang · 1 shared paper, 2024 · strength 0.20
- Xiaojia Li · 1 shared paper, 2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.